The quark-meson coupling model, based on a mean field description of
non-overlapping nucleon bags bound by the self-consistent exchange of $\sigma$,
$\omega$ and $\rho$ mesons, is extended to investigate the properties of finite
nuclei. Using the Born-Oppenheimer approximation to describe the interacting
quark-meson system, we derive the effective equation of motion for the nucleon,
as well as the self-consistent equations for the meson mean fields. The model
is first applied to nuclear matter, after which we show some initial results
for finite nuclei.Comment: The revised version. This is tar, compressed and uuencoded (including
3 tables and 8 figures). 45 page
We calculate the valence distribution of down quarks in the proton and up quarks in the neutron (the ‘minority’ quark distributions), taking into consideration the major sources of charge symmetry violation, including the effect of the mass difference of the u and d quarks on the bag wave function, and the masses of the intermediate diquark states. The relative difference of the distributions can be as large as 10% for intermediate values of Bjorken x.
We extend earlier investigations of charge symmetry violation in the valence quark distributions of the nucleon, and make similar estimates for the pion. The sensitivity of pion-induced Drell-Yan measurements to such effects is then examined. It is shown that combinations of π + and π − data on deuterium and hydrogen are sensitive to these violations, and that the pion and nucleon charge symmetry violating terms separate as a function of x π and x N respectively. We estimate the background terms which must be evaluated to extract charge symmetry violation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.